There’s a year-end rush in all aspects of life. Businesses try to run up profits in December. Supervisors want to…
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing…